Chemocentryx Shares Owned by Institutions

CCXI -  USA Stock  

USD 14.37  0.62  4.14%

Chemocentryx fundamentals help investors to digest information that contributes to Chemocentryx's financial success or failures. It also enables traders to predict the movement of Chemocentryx Stock. This fundamental analysis module provides a way for investors to measures Chemocentryx's intrinsic value by examining all of its available economic and financial indicators and drivers, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Chemocentryx stock. Please note, this module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Search Shares Owned by Institutions 

 
Refresh

Chemocentryx Shares Owned by Institutions Analysis

Chemocentryx's Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
 2018 2019 2020 2021 (projected)
Interest Expense1.22 M2.15 M2.64 M2.85 M
Gross Profit42.88 M36.13 M64.89 M54.5 M
Shares Held by Institutions 
 = 
Funds and Banks 
Firms 
More About Shares Owned by Institutions | All Equity Analysis

Current Chemocentryx Shares Owned by Institutions

    
  72.45 %  
Most of Chemocentryx's fundamental indicators, such as Shares Owned by Institutions, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Chemocentryx is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Chemocentryx Shares Owned by Institutions Driver Correlations

Understanding the fundamental principles of building solid financial models for Chemocentryx is extremely important. It helps to project a fair market value of Ford stock properly, considering its historical fundamentals such as Shares Owned by Institutions. Since Chemocentryx's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Chemocentryx's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Chemocentryx's interrelated accounts and indicators.
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
Compare to competition

Based on the latest financial disclosure, 72% of Chemocentryx are shares owned by institutions. This is 62.3% higher than that of the Healthcare sector and 52.53% higher than that of the Biotechnology industry. The shares owned by institutions for all United States stocks is 84.77% lower than that of the firm.

Chemocentryx Current Valuation Drivers

We derive many important indicators used in calculating different scores of Chemocentryx from analyzing Chemocentryx's financial statements. These drivers represent accounts that assess Chemocentryx's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Chemocentryx's important valuation drivers and their relationship over time.
201620172018201920202021 (projected)
Net Income Per Employee(642.8 K)270.59 K(499.55 K)(676.7 K)(415.07 K)(447.84 K)
Average Assets124.81 M152.54 M190.61 M223.14 M447.82 M483.18 M
Earnings Before Interest Taxes and Depreciation Amortization EBITDA(39.62 M)18.28 M(36.23 M)(51.7 M)(49.95 M)(51.26 M)
Earnings Before Interest Taxes and Depreciation Amortization USD(39.62 M)18.28 M(36.23 M)(51.7 M)(49.95 M)(51.26 M)
Earnings before Tax(39.96 M)17.86 M(37.97 M)(55.49 M)(55.36 M)(56.81 M)
Average Equity55.9 M50.95 M22.66 M69.99 M317.93 M343.03 M
Enterprise Value339.9 M272.2 M541.85 M2.29 B4.29 B4.63 B
Free Cash Flow38.84 M4.16 M15.6 M(70.91 M)(96.55 M)(99.09 M)
Invested Capital105.51 M121.05 M110.52 M131.18 M498.12 M537.44 M
Invested Capital Average85.79 M87.97 M98.42 M135.44 M323.79 M349.35 M
Market Capitalization353.76 M290.16 M551.24 M2.3 B4.29 B4.62 B
Tangible Asset Value155.87 M189.33 M183.31 M209.08 M518.9 M559.86 M
Working Capital110.36 M146.89 M116.99 M115.28 M390.01 M420.8 M

Chemocentryx Institutional Holders

Institutional Holdings refers to the ownership stake in Chemocentryx that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Chemocentryx's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Chemocentryx's value.
Security TypeSharesValue
Assenagon Asset Management SaCommon Shares104.2 K1.4 M
Cutler Group LpPut Options108.9 K960 K
Belvedere Trading LlcCommon Shares34.1 K550 K
Cutler Group LpCommon Shares38.6 K516 K
Valeo Financial Advisors LlcCommon Shares10 K134 K
Cutler Group LpCall Options58.2 K129 K
Ifp Advisors IncCommon Shares0.00.0
Fmr LlcCommon Shares10.4 M535 M
Wellington Management Group LlpCommon Shares6.1 M313.1 M

Chemocentryx Fundamentals

About Chemocentryx Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Chemocentryx's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Chemocentryx using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Chemocentryx based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
ChemoCentryx, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. ChemoCentryx, Inc. was incorporated in 1996 and is headquartered in Mountain View, California. Chemocentryx operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 133 people.

Chemocentryx Investors Sentiment

The influence of Chemocentryx's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Chemocentryx. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Current Sentiment - CCXI

Chemocentryx Investor Sentiment

Most of Macroaxis users are currently bullish on Chemocentryx. What is your opinion about investing in Chemocentryx? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Pair Trading with Chemocentryx

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Chemocentryx position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chemocentryx will appreciate offsetting losses from the drop in the long position's value.

Chemocentryx Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for Chemocentryx and Dynavax Technologies. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Continue to Chemocentryx Piotroski F Score and Chemocentryx Altman Z Score analysis. Note that the Chemocentryx information on this page should be used as a complementary analysis to other Chemocentryx's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Complementary Tools for Chemocentryx Stock analysis

When running Chemocentryx price analysis, check to measure Chemocentryx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemocentryx is operating at the current time. Most of Chemocentryx's value examination focuses on studying past and present price action to predict the probability of Chemocentryx's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Chemocentryx's price. Additionally, you may evaluate how the addition of Chemocentryx to your portfolios can decrease your overall portfolio volatility.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
The market value of Chemocentryx is measured differently than its book value, which is the value of Chemocentryx that is recorded on the company's balance sheet. Investors also form their own opinion of Chemocentryx's value that differs from its market value or its book value, called intrinsic value, which is Chemocentryx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemocentryx's market value can be influenced by many factors that don't directly affect Chemocentryx underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chemocentryx's value and its price as these two are different measures arrived at by different means. Investors typically determine Chemocentryx value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemocentryx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.